Koolteer
Generic name
Koolteer
Brand name
ATC Code
D05AA
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No data available
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Psoriasis and infantile seborrhoeic dermatitis |
|---|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIPSORIATICS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| ANTIPSORIATICS FOR TOPICAL USE | ||
|---|---|---|
| D05AX02 | ||
| D05AX03 | ||
References
- Pfizer BV, SmPC Denorex (RVG 12594) 03-12-2018, www.geneesmiddeleninformatiebank.nl
- Trans Dermal Nederland B.V., SmPC Exorex (RVG 22715) 29-04-2014, www.geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
